vs
AMPCO PITTSBURGH CORP（AP）与Axsome Therapeutics, Inc.（AXSM）财务数据对比。点击上方公司名可切换其他公司
Axsome Therapeutics, Inc.的季度营收约是AMPCO PITTSBURGH CORP的1.8倍（$191.2M vs $104.4M），Axsome Therapeutics, Inc.同比增速更快（57.4% vs 11.5%），过去两年Axsome Therapeutics, Inc.的营收复合增速更高（48.1% vs -2.6%）
安普科匹兹堡公司是一家特种钢材制造商，总部位于宾夕法尼亚州匹兹堡市中心，1929年由多家此前已成立的小型钢铁企业合并组建而成。需要注意区分它和其他同样带有Ampco名称的企业，比如位于密尔沃基的铜基合金生产商、迈阿密的橱柜企业等。
Jazz Pharmaceuticals是一家全球生物制药企业，专注于肿瘤学与神经科学领域的药物研发及商业化。公司2003年在美国加利福尼亚州成立，目前总部位于爱尔兰都柏林，业务覆盖全球多个核心市场。
AP vs AXSM — 直观对比
营收规模更大
AXSM
是对方的1.8倍
$104.4M
营收增速更快
AXSM
高出46.0%
11.5%
两年增速更快
AXSM
近两年复合增速
-2.6%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $104.4M | $191.2M |
| 净利润 | $-57.7M | — |
| 毛利率 | — | — |
| 营业利润率 | -54.0% | -33.1% |
| 净利率 | -55.2% | — |
| 营收同比 | 11.5% | 57.4% |
| 净利润同比 | -1958.9% | — |
| 每股收益（稀释后） | $-2.87 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APAXSM
| Q1 26 | — | $191.2M | ||
| Q4 25 | $104.4M | $196.0M | ||
| Q3 25 | $103.7M | $171.0M | ||
| Q2 25 | $108.9M | $150.0M | ||
| Q1 25 | $99.2M | $121.5M | ||
| Q4 24 | $93.6M | $118.8M | ||
| Q3 24 | $92.1M | $104.8M | ||
| Q2 24 | $107.1M | $87.2M |
净利润APAXSM
| Q1 26 | — | — | ||
| Q4 25 | $-57.7M | $-28.6M | ||
| Q3 25 | $-2.2M | $-47.2M | ||
| Q2 25 | $-7.3M | $-48.0M | ||
| Q1 25 | $1.1M | $-59.4M | ||
| Q4 24 | $3.1M | $-74.9M | ||
| Q3 24 | $-2.0M | $-64.6M | ||
| Q2 24 | $2.0M | $-79.3M |
营业利润率APAXSM
| Q1 26 | — | -33.1% | ||
| Q4 25 | -54.0% | -13.8% | ||
| Q3 25 | 1.1% | -27.0% | ||
| Q2 25 | -2.8% | -24.5% | ||
| Q1 25 | 3.9% | -46.9% | ||
| Q4 24 | 5.5% | -61.1% | ||
| Q3 24 | 2.0% | -59.8% | ||
| Q2 24 | 4.7% | -89.5% |
净利率APAXSM
| Q1 26 | — | — | ||
| Q4 25 | -55.2% | -14.6% | ||
| Q3 25 | -2.1% | -27.6% | ||
| Q2 25 | -6.7% | -32.0% | ||
| Q1 25 | 1.2% | -48.9% | ||
| Q4 24 | 3.3% | -63.1% | ||
| Q3 24 | -2.1% | -61.7% | ||
| Q2 24 | 1.9% | -91.0% |
每股收益（稀释后）APAXSM
| Q1 26 | — | — | ||
| Q4 25 | $-2.87 | $-0.55 | ||
| Q3 25 | $-0.11 | $-0.94 | ||
| Q2 25 | $-0.36 | $-0.97 | ||
| Q1 25 | $0.06 | $-1.22 | ||
| Q4 24 | $0.16 | $-1.54 | ||
| Q3 24 | $-0.10 | $-1.34 | ||
| Q2 24 | $0.10 | $-1.67 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $10.7M | $305.1M |
| 总债务越低越好 | $117.9M | $70.0M |
| 股东权益账面价值 | $32.6M | — |
| 总资产 | $495.4M | $713.6M |
| 负债/权益比越低杠杆越低 | 3.61× | — |
8季度趋势，按日历期对齐
现金及短期投资APAXSM
| Q1 26 | — | $305.1M | ||
| Q4 25 | $10.7M | $322.9M | ||
| Q3 25 | $15.0M | $325.3M | ||
| Q2 25 | $9.9M | $303.0M | ||
| Q1 25 | $7.1M | $300.9M | ||
| Q4 24 | $15.4M | $315.4M | ||
| Q3 24 | $11.8M | $327.3M | ||
| Q2 24 | $7.9M | $315.7M |
总债务APAXSM
| Q1 26 | — | $70.0M | ||
| Q4 25 | $117.9M | — | ||
| Q3 25 | $119.0M | — | ||
| Q2 25 | $115.9M | — | ||
| Q1 25 | $115.0M | — | ||
| Q4 24 | $116.4M | — | ||
| Q3 24 | $116.0M | — | ||
| Q2 24 | $119.4M | — |
股东权益APAXSM
| Q1 26 | — | — | ||
| Q4 25 | $32.6M | $88.3M | ||
| Q3 25 | $60.1M | $73.7M | ||
| Q2 25 | $62.7M | $73.1M | ||
| Q1 25 | $64.6M | $53.2M | ||
| Q4 24 | $58.9M | $57.0M | ||
| Q3 24 | $61.3M | $92.9M | ||
| Q2 24 | $58.0M | $102.9M |
总资产APAXSM
| Q1 26 | — | $713.6M | ||
| Q4 25 | $495.4M | $689.8M | ||
| Q3 25 | $524.4M | $669.3M | ||
| Q2 25 | $537.2M | $639.8M | ||
| Q1 25 | $536.2M | $596.7M | ||
| Q4 24 | $530.9M | $568.5M | ||
| Q3 24 | $547.4M | $561.5M | ||
| Q2 24 | $560.8M | $548.2M |
负债/权益比APAXSM
| Q1 26 | — | — | ||
| Q4 25 | 3.61× | — | ||
| Q3 25 | 1.98× | — | ||
| Q2 25 | 1.85× | — | ||
| Q1 25 | 1.78× | — | ||
| Q4 24 | 1.98× | — | ||
| Q3 24 | 1.89× | — | ||
| Q2 24 | 2.06× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.7M | — |
| 自由现金流经营现金流 - 资本支出 | $-64.0K | — |
| 自由现金流率自由现金流/营收 | -0.1% | — |
| 资本支出强度资本支出/营收 | 2.7% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-8.1M | — |
8季度趋势，按日历期对齐
经营现金流APAXSM
| Q1 26 | — | — | ||
| Q4 25 | $2.7M | $-18.7M | ||
| Q3 25 | $6.3M | $1.0M | ||
| Q2 25 | $-2.3M | $-32.4M | ||
| Q1 25 | $-5.3M | $-43.4M | ||
| Q4 24 | $7.5M | $-26.2M | ||
| Q3 24 | $11.4M | $-18.6M | ||
| Q2 24 | $-5.3M | $-30.1M |
自由现金流APAXSM
| Q1 26 | — | — | ||
| Q4 25 | $-64.0K | $-18.7M | ||
| Q3 25 | $3.3M | $988.0K | ||
| Q2 25 | $-3.8M | $-32.4M | ||
| Q1 25 | $-7.5M | $-43.7M | ||
| Q4 24 | $3.7M | $-26.2M | ||
| Q3 24 | $8.4M | $-18.7M | ||
| Q2 24 | $-8.0M | $-30.2M |
自由现金流率APAXSM
| Q1 26 | — | — | ||
| Q4 25 | -0.1% | -9.6% | ||
| Q3 25 | 3.2% | 0.6% | ||
| Q2 25 | -3.5% | -21.6% | ||
| Q1 25 | -7.5% | -36.0% | ||
| Q4 24 | 4.0% | -22.1% | ||
| Q3 24 | 9.1% | -17.9% | ||
| Q2 24 | -7.5% | -34.6% |
资本支出强度APAXSM
| Q1 26 | — | — | ||
| Q4 25 | 2.7% | 0.0% | ||
| Q3 25 | 2.9% | 0.0% | ||
| Q2 25 | 1.3% | 0.0% | ||
| Q1 25 | 2.2% | 0.3% | ||
| Q4 24 | 4.0% | 0.0% | ||
| Q3 24 | 3.2% | 0.1% | ||
| Q2 24 | 2.5% | 0.1% |
现金转化率APAXSM
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -4.62× | — | ||
| Q4 24 | 2.40× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -2.64× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AP
| Forged And Cast Mill Rolls | $67.0M | 64% |
| Air Handling Systems | $14.3M | 14% |
| Heat Exchange Coils | $13.1M | 13% |
| Centrifugal Pumps | $10.3M | 10% |
| Forged Engineered Products | $4.0M | 4% |
AXSM
| Product sales, net | $189.4M | 99% |
| Royalty revenue and milestone revenue | $1.8M | 1% |
